Patient Participant Perspectives on Implementation of Long-Acting Cabotegravir and Rilpivirine: Results From the Cabotegravir and Rilpivirine Implementation Study in European Locations (CARISEL) StudyCassidy A. Gutner, Maggie Czarnogorski, Marc van der Valk et al.|Journal of the International Association of Providers of AIDS Care (JIAPAC)|2024Cited by 14
Persistently normal blood tests in patients taking methotrexate for RA or azathioprine for IBD: a retrospective cohort studySimon Fraser, Christopher J Edwards, Nicola Barnes et al.|British Journal of General Practice|2022Cited by 13
(untitled)Sharon Lin, Simon Fraser, Thomas Phillips et al.|University of Brighton Repository (University of Brighton)|0Cited by 10
P-1899. Improvement in Provider Experiences from Baseline to Month 12 with Integrating Cabotegravir Long-Acting (CAB LA) for PrEP into Care in an Implementation Science Trial (PILLAR)Taimur Khan, Nanlesta Pilgrim, Jonathan M. L. White et al.|Open Forum Infectious Diseases|2025Cited by 0